Wyenne Davis Pharmaceuticals Private Limited, a active private limited company, was established on 02 December 2011 in Palakkad, Kerala, India. Engaging in wholesale within the trade sector, it holds CIN: U24233KL2011PTC029962. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹0.60 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Vijayakumar Krishnan (Director), Thiruvil Ramchandran (Managing Director), Areeckal Midhun (Director). Past directors included Thiruvil Ramchandran, Saji Balan, Balasubramanian Aandiveedu Vipin. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at N0. 12/355, Hebbar Compound Chandranagar, Palakkad, Kerala, 678007.
U24233KL2011PTC029962
029962
02 December 2011
₹0.60 M
₹0.50 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Wyenne Davis Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vijayakumar Krishnan | Director | 02 Dec 2011 | Current |
| Thiruvil Ramchandran | Managing Director | 02 Dec 2011 | Current |
| Areeckal Midhun | Director | 08 Jul 2017 | Current |
| Ratheesh Chakyatt | Director | 08 Jul 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 11 Mar 2015 | Past |
| Pramod Abcsdd | Managing Director | 11 Mar 2015 | Past |
| Pramod Abcsdd | Director | 08 Aug 2012 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Wyenne Davis Pharmaceuticals Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 35.74% increase. The company also saw a substantial improvement in profitability, with a 38.36% increase in profit. The company's net worth moved up by a moderate rise of 2.46%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2016, Wyenne Davis Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Wyenne Davis Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Wyenne Davis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wyenne Davis Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Wyenne Davis Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Wyenne Davis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was recorded as a recent event.
Progress on Areeckal Midhun was appointed as a Director was appointed as a Director on 08 Jul 2017 & has been associated with this company since 8 years 4 months . was documented.
Progress on Ratheesh Chakyatt was appointed as a Director was appointed as a Director on 08 Jul 2017 & has been associated with this company since 8 years 4 months . was documented.
Vijayakumar Krishnan was appointed as a Director was appointed as a Director on 02 Dec 2011 & has been associated with this company since 14 years . was recorded as a recent event.
Progress on Thiruvil Ramchandran was appointed as a Managing Director was appointed as a Managing Director on 02 Dec 2011 & has been associated with this company since 14 years . was documented.
The CIN of Wyenne Davis Pharmaceuticals Private Limited is U24233KL2011PTC029962.
Wyenne Davis Pharmaceuticals Private Limited is headquartered at N0. 12/355, Hebbar Compound Chandranagar, Palakkad, Kerala, 678007.
Wyenne Davis Pharmaceuticals Private Limited was incorporated on 02 December 2011.
The current directors of Wyenne Davis Pharmaceuticals Private Limited are
The primary industry of Wyenne Davis Pharmaceuticals Private Limited is Trade.
Wyenne Davis Pharmaceuticals Private Limited is unlisted.
The authorized capital of Wyenne Davis Pharmaceuticals Private Limited is ₹0.60 M, and the paid-up capital is ₹0.50 M.
The compliance status of Wyenne Davis Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX